Screener
Myriad Genetics MYGN Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The source filing: Myriad Genetics’s 10-K, filed February 24, 2026.
- Filed
- Feb 24, 2026, 4:01 PM EST
- Fiscal year
- FY2025
- Accession
- 0000899923-26-000018
| Year Ended (in millions): | ||
|---|---|---|
| 2029 | 12.7 | |
| 2030 | 11.8 | |
| Thereafter | 62.0 | |
| Total future lease payments | 124.8 | |
| Less: amounts representing interest | 34.9 | |
| Present value of future lease payments | 89.9 | |
| Less: current maturities of operating lease liabilities | (6.9) | |
| Noncurrent operating lease liabilities | $ | $83.0 |
Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is Myriad Genetics's operating lease liabilities (total)?
- Myriad Genetics (MYGN) reported operating lease liabilities (total) of $89.9M in Q4 2025.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.
Ask your AI about Myriad Genetics's operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude